细胞分离GvHD与GvL的细胞策略在偶同移植中
Mauro Di Ianni1,2,3, Carmine Liberatore1, Nicole Santoro1
1Hematology Unit, Pescara Hospital, 65124 Pescara, Italy.
Cells
|January 22, 2024
概括
移植与宿主疾病 (GvHD) 仍然是异构移植的主要并发症. 本综述探讨了先进的细胞疗法,包括TCRα/β枯竭和NK细胞免疫疗法,以将GvHD与移植与白血病 (GvL) 效应分开.
科学领域:
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
- 细胞疗法细胞疗法
背景情况:
- 移植与宿主疾病 (GvHD) 是所有原性干细胞移植后的一个显著和可怕的并发症.
- 从GvHD中分离有益的移植与白血病 (GvL) 效应仍然是该领域的一个关键挑战.
研究的目的:
- 审查目前和新兴的细胞治疗策略,旨在预防GvHD.
- 探索在异种移植中最大限度地提高GvL效应,同时最大限度地减少GvHD的方法.
- 专注于在哈普罗同一移植的背景下应用.
主要方法:
- 对用于预防GvHD的细胞疗法技术现有文献的审查.
- 分析包括T细胞受体 (TCR) α/β消耗在内的策略.
- 评估CD45RA枯竭,调控性T细胞丰富,NK细胞基础免疫疗法和自杀性基因疗法.
主要成果:
- 各种细胞疗法方法在缓解GvHD方面表现有前途.
- 像TCRα/β耗尽和NK细胞疗法等技术为选择性GvL增强提供了潜在的潜力.
- 优化这些疗法可能会导致对平分异构移植的改善结果.
结论:
- 先进的细胞疗法对于克服GvHD障碍在异种移植中至关重要.
- 通过精细的细胞操纵技术,可以实现GvL效应的选择性增强.
- 这些策略具有显著的潜力,可以提高平分相同干细胞移植的安全性和有效性.
相关概念视频
Bone Marrow Sampling and Transplants
332
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
332
Tissue Transplantation
372
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
372
Cell-mediated Immune Responses
68.3K
Overview
68.3K


